This summer institute, in the nation’ capital, explores how innovative drugs and devices are developed and regulated. You will have the opportunity to:
- Visit the Food and Drug Administration (FDA) and the National Institute of Health (NIH),
- Listen to policy experts and thought leaders explain the ramifications of proposed regulatory initiatives, and
- Solve case studies with regulatory and quality professionals from around the world.
This institute is an international, multi-disciplinary program organized through collaborations between the GW School of Medicine and Health Sciences, the GW Law School, and the European Center of Pharmaceutical Medicine (ECPM) at the University of Basel, Switzerland.
The course is open to current GW graduate students, as well as visiting students (e.g., biomedical engineers, medical doctors, J.D. candidates, and entrepreneurs in the life-science field, etc.) interested in drug and device development and the regulatory aspects of translational research.
- 3-credit GW course: Tuition (3 credit hours - School of Medicine & Health Sciences) + $230 Program Fee
- Conference-Only Option: $1600
- Discounted Conference-Only Option: $950
- One-Day Conference Pass: $500
Discounts are available to the following individuals who wish to attend the conference only:
- Academic: Available to those with a current full-time position at an educational institution.
- NGO's: Available to employees of registered NGO's only.
- Governmental organizations: Available for employees of a local, regional, national, or federal government organization.
- Advisory Boards Organizations: Available to those with a current full-time position at an organization, which has an employee serving in the Advisory Board of the Regulatory Affairs Master Program at GW, or in the Advisory Board of the Master of Medicines Development (MDD) at the University of Basel, Switzerland.
If you have questions about qualifying for the discounted price, please contact Ms. Melanie Trask at firstname.lastname@example.org.
Dr. Daniela Drago, the program director, is a GW faculty member and has a strong background in the pharmaceutical and medical device industry.
Partners at ECPM, University of Basel
Dr. Thomas Szucs, is Professor in Pharmaceutical Medicine and Director of ECPM, University of Basel.
Dr. Annette Mollet, is the Head of Education and Training at ECPM, University of Basel.
Partner at GW Law School
Dr. Neil Ruiz, is the Executive Director of the Center for Law, Economics, and Finance at GW Law School. He leads a new entrepreneurship initiative at the Law School.
Online: May 8 - June 24, 2017
In-Person: May 22-25, 2017
Faculty Conference Center, GW Law School (20th Street NW, Washington DC)
For further information and to register, please contact Ms. Melanie Trask at email@example.com.